Correlation Between Bram Indus and Infimer
Can any of the company-specific risk be diversified away by investing in both Bram Indus and Infimer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bram Indus and Infimer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bram Indus and Infimer, you can compare the effects of market volatilities on Bram Indus and Infimer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bram Indus with a short position of Infimer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bram Indus and Infimer.
Diversification Opportunities for Bram Indus and Infimer
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bram and Infimer is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Bram Indus and Infimer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Infimer and Bram Indus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bram Indus are associated (or correlated) with Infimer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Infimer has no effect on the direction of Bram Indus i.e., Bram Indus and Infimer go up and down completely randomly.
Pair Corralation between Bram Indus and Infimer
Assuming the 90 days trading horizon Bram Indus is expected to generate 245.14 times less return on investment than Infimer. But when comparing it to its historical volatility, Bram Indus is 86.59 times less risky than Infimer. It trades about 0.11 of its potential returns per unit of risk. Infimer is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 1,860,000 in Infimer on September 24, 2024 and sell it today you would lose (960,000) from holding Infimer or give up 51.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bram Indus vs. Infimer
Performance |
Timeline |
Bram Indus |
Infimer |
Bram Indus and Infimer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bram Indus and Infimer
The main advantage of trading using opposite Bram Indus and Infimer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bram Indus position performs unexpectedly, Infimer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infimer will offset losses from the drop in Infimer's long position.Bram Indus vs. Analyst IMS Investment | Bram Indus vs. Clal Insurance Enterprises | Bram Indus vs. IBI Mutual Funds | Bram Indus vs. Mobile Max M |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |